Overview

Absorption, Distribution, Metabolism And Excretion Study For GSK221149A

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a phase one study investigating the absorption, distribution, metabolism and excretion of GSK221149A in six healthy women of non-child bearing potential.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline